Manulife (Manufacturers Life Insurance)’s Damora Therapeutics DMRA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$366K	Buy	+14,066	New	+$341K	﹤0.01%	2343

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Manulife (Manufacturers Life Insurance)'s DMRA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 14,066 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #2343 among its holdings.

104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Manulife (Manufacturers Life Insurance) held 14,066 shares of Damora Therapeutics worth $366K as of Q2 2026.
Damora Therapeutics was a new Manulife (Manufacturers Life Insurance) position in Q2 2026.
Damora Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2343 holding.
104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.